UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Clinical trials for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fighting tough cancers with a Patient's own supercharged immune cells
Disease control OngoingThis study is testing a personalized cell therapy called LN-145 for patients with advanced cancers that have stopped responding to standard treatments. Doctors collect a patient's own immune cells from their tumor, grow large numbers of them in a lab, and then infuse them back in…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for tough sarcomas: adding a targeted drug to standard treatment
Disease control OngoingThis study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New Two-Pronged attack tested against rare cancers before surgery
Disease control OngoingThis early-stage study is testing the safety of combining two immunotherapy drugs, nivolumab and BO-112, given before surgery for patients with operable soft tissue sarcoma. The goal is to see if stimulating the immune system to attack the tumor before it is removed can improve o…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC